Twelve Chinese pharmaceutical companies are appealing a court ruling that sides with Pfizer Inc. and prevents local drug makers from selling generic versions of Viagra, a state-run newspaper said Tuesday.

The companies filed the appeal Monday at Beijing’s High People’s Court, calling for the reversal of the June 5 decision by a lower court to uphold Pfizer’s patent for the impotence drug, the China Daily said.